To date, the available evidence about the safety and efficacy of the anthrax vaccine is resoundingly negative. Three US government anthrax vaccine initiatives represent a reckless deviation from the precautionary principle of medical ethics and fiscal responsibility. Continue reading →
Whose children will be sacrificed in an illegal and unethical experiment in the name of Biodefense Preparedness? Continue reading →
"When my brother went into the hospital with pneumonia, he quickly contracted four other infections in the intensive care unit…Michael died in the ICU." Maureen Dowd, NYT Columnist.
When is it moral for a government policy to compel parents to expose their child to risk of suffering serious, irreversible injury, or even death–so that other children would live? That overriding moral question is what public health officials and the stakeholders . . . Continue reading →
"The vote is an enormous blow to Avandia and GlaxoSmithKline. The vast majority of panel members voted either to withdraw the drug or to allow continued sales only if strict controls are added" Continue reading →
On March 22, 2010 the FDA recommended suspension in the use of GlaxoSMithKline’s Rotarix vaccine–to prevent rotavirus (diarrhea)–due to contamination with pig virus. Rotarix, one of two vaccines licensed in the U.S , has already been given to about 1 million U.S. children along with 30 million worldwide.
Continue reading →
A large-scale Harvard meta-analysis published in the Journal of the American Medical Association, is the first ever to evaluate the relationship between different anticonvulsant drugs and the risk of suicide in for patients with diverse diagnoses: " the risk was derived from the specific drug that the patient was taking and not their underlying conditions." Continue reading →
Columbia Journalism Review–The Complicity of the Media in Drug Marketing Wed, 27 Jul 2005 An excellent article in the Columbia Journalism Review examines pharmaceutical industry hype and the media’s role in helping that industry create false impressions about the safety and benefits . . . Continue reading →
FDA Slaps Pfizer on Zoloft Ads After AHRP Files Complaint Sat, 07 May 2005 On November 4, 2004, AHRP filed a complaint with the FDA about a two page Pfizer advertisement for its SSRI antidepressant, Zoloft. The ad appeared in The New . . . Continue reading →
FDA New Drug Safety Website – ADHD A Huge Profit-Engine for amphetamine-like drugs – The Street Sun, 22 May 2005 “After 25 years and 35 studies, there is not a single straightforward experiment comparing typical unmedicated children with an ADHD diagnosis to . . . Continue reading →